Interaction of ligand with protein based on initial 50 ns simulation
N Engl J Med 366:15771585 Koehler JA, Baggio LL, Yusta B et al (2015) GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7
In addition to worsening symptoms such as headache, dizziness, and vomiting mentioned above, ataxia, mental confusion, varying degrees of consciousness disorders, fever, and in severe cases, brain herniation can occur, endangering life (Li et al., 2023).The exact pathophysiological mechanisms underlying the development of AMS and HACE have not been fully determined
It may also cause adverse interactions with monoamine oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs).[2] People who take Vyvanse may experience mild side effects
GLP-1s are transformative medications - price transparency, expanding clinical indications, and direct-to-plan pricing models will influence future plan designs
DollSFreitasFPShahRAldrovandiMda SilvaMCIngoldIet al